# A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction (IR)

> **NCT02119832** · NA · COMPLETED · sponsor: **C. R. Bard** · enrollment: 17 (actual)

## Conditions studied

- Chronic Kidney Disease (CKD)

## Interventions

- **DEVICE:** Endovasccular AVF (EndoAVF)

## Key facts

- **NCT ID:** NCT02119832
- **Lead sponsor:** C. R. Bard
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02119832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02119832, "A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction (IR)". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT02119832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*